Best Life Sciences Companies in Stockholm County, Sweden

Provider of a biology platform that detects cell-cell interactions within their tissue environment. It offers functional profiling platform that allows scientists to map cell-cell communication directly in clinical tissue, providing insights of the cellular complexity in health and disease.

Funding rounds

• May 2026Series A$20M
• Jun 2024Series A$26M

Founders & team

Olle EricssonFounder and CEO

Investors

Arch Venture Partners, Eir Ventures, Rubicon Healthcare Partners

Tech stack

AxiosCloudflareCloudflare Bot ManagementCookiebotCore-JsFacebook Pixel

BioLamina is a biotechnology company that manufactures full-length human recombinant laminins for primary and stem-cell culture applications. The company's product portfolio includes recombinant laminins as cell culture matrices for specific uses like pluripotent stem cell culture, early epithelial development and differentiation, and kits with multiple laminins for screening the most appropriate matrix for specific cell types.

Funding rounds

• Apr 2026Conventional Debt$23.6M
• Sep 2023Series B$18.2M
• Apr 2021Grant (prize money)$444.3K
• Aug 2009Grant (prize money)$331.6K

Founders & team

Magnus KennebyCo-FounderKristian TryggvasonFounder

Investors

Lauxera Capital Partners, Bure Equity, Northislet, Europa, HHS, European Investment Bank

Tech stack

Amazon S3Amazon Web ServicesAnimate.CssAutoptimizeCart FunctionalityCloudflare

Developer of personalized immunotherapeutics for oncology, autoimmune and inflammatory diseases. The company has TCR-modified T-cell therapies against multiple antigen classes, tumours, genetic mutations, and viruses that cause cancer. The proprietary Immuno-technology platform for its target discovery, validation, and product development.

Developer of therapies to treat metabolic and chronic lifestyle diseases. The company has developed a material platform technology, SiPore an orally administered silica-based powder product. It has multiple applications including gestational and pediatric type 2 diabetes and obesity, modulation of the gut microbiome, treatment of excessive bile acid levels post-bariatric surgery, NASH, weight loss, and infantile colic.

Funding rounds

• Jan 2026Series C$5M
• Oct 2023Series B$4M
• Jan 2023Series A$1M
• Nov 2021Series A$8.4M

Founders & team

Sana AlajmovicCo-Founder & CEO

Investors

Joyance Partners, Crosslight Partners, Irrus Investments, Almi Invest, Axilium Holding, Uppsala Innovation Centre

Tech stack

AngularCart FunctionalityCore-JsElementorGoogle AnalyticsGoogle Font Api

Developer of therapeutics to treat cancers, inflammation, and autoimmune diseases. It offers one-carbon metabolism pathway-based therapeutics that target DNA repair and DNA damage response for the treatment of BRCA mutated cancer with PARP inhibitors.

Developer of therapeutics for fibrotic diseases. The medicines target the CCN protein family which is a group of signaling proteins central to the development of fibrosis; the process of exaggerated scar tissue formation.

Funding rounds

• Mar 2025Series A$24.8M
• 2020Seed$16M

Founders & team

Havard AttramadalCo-FounderOle KaasbollCo-FounderGeorg BeiskeCo-Founder & CEO

Investors

Novo Holdings, LifeArc Ventures, Healthcap, Innovestor, Industrifonden, Investinor

Tech stack

BootstrapCloudflareCloudflare Bot ManagementGoogle AnalyticsHttp/3Jquery

Developer of therapeutics for hepatic encephalopathy (HE). Its proprietary platform uses small molecules that inhibit the action of GABA-steroids in the brain. Its lead candidate GR3027 is currently in phase 2a of clinical trials and can be used in both acute life-threatening HE, as well as minimal chronic HE.

Funding rounds

• May 2025Grant (prize money)$420K
• Mar 2023Series A$3M
• Sep 2022Series A$3.9M
• Jul 2021Series A$4.1M

Founders & team

Viktor DrvotaCEO

Investors

Almi Invest, Fort Knox, Norrlandsfonden, Karolinska Development, Partnerinvest Norr, Ribbskottet

Developer of therapeutics for neurological disorders. It offers lead candidate ACD856 a positive modulator of Trk-receptors from the NeuroRestore platform for the treatment of Alzheimer's, Parkinson's disease, and related neurological diseases.

Observe Medical has developed, Sippi, a single use, digital urine meter which measures biofilm build-up via non-contact capacitive sensors, delivering constant throughput, and incorporating hourly diuresis, data storage and automatic emptying.

Developer of immunotherapies for cancer and autoimmune therapies. It offers Seqitope an antibody epitope mapping method, Opti-mAb for CAR-T cells, and bispecific antibodies development for cancer treatment.

Funding rounds

• Feb 2026Seed—
• Oct 2024Seed$684.9K

Founders & team

Maria KnudsenCEO

Investors

KI Holding, Northislet, Phase2Phase

Tech stack

AngularCart FunctionalityCore-JsGoogle Font ApiHstsMicrosoft 365

Developer of radiopharmaceuticals for the treatment of cancer. The company has pTTL cell therapy product, which targets neoantigens by using proprietary PIOR and patented EpiTCer technologies, targeting neoantigens using immune cells from cancer patients as starting material.

Funding rounds

• Feb 2026Series A$9.8M
• Mar 2024Seed$473K
• Nov 2023Grant (prize money)$2.6M
• 2023Grant (prize money)$8.9M

Founders & team

Samuel SvenssonCEO

Investors

EIC Fund, Okomera, Eureka, Europa, Sciety, Northislet

Tech stack

Animate.CssCloudflareCloudflare Bot ManagementCookie NoticeCore-JsElementor

Provider of personalized nutrition plans and coaching services for children. It utilizes microbiome science and AI to provide personalized nutrition plans and coaching for families based on gut microbiome test for children to support healthy development and well-being from a young age.

Funding rounds

• May 2025Seed$2.5M
• Jun 2023Seed$2M
• Grant (prize money)$500K

Founders & team

Willem De VosCo-FounderEleonora CavaniCo-Founder & CEO

Investors

Voima Ventures, Octopus Ventures, Noaber Foundation, Bust, Joyance Partners, BioInnovation Institute

Tech stack

CloudflareCloudflare Browser InsightsCookiebotCore-JsEverflowFacebook Pixel